News

   

Recent Prasco News

2016

Prasco Expands Its Portfolio Through Acquisition of Teva’s Authorized Generic of Adderall XR® (Mixed Salts of a Single-Entity Amphetamine Product) Extended Release Capsules, CII

AS RELEASED 6.28.16 Prasco Expands Its Portfolio Through Acquisition of Teva’s Authorized Generic of Adderall XR® (Mixed Salts of a Single-Entity Amphetamine Product) Extended Release Capsules, CII Cincinnati, OH, June 28, 2016/PRNewswire/ — Prasco Laboratories (“Prasco”) today announced that it has entered...

 

2015

Prasco and Takeda Enter into Agreement to Market Authorized Generic of Colcrys® (colchicine, USP) in the United States

AS RELEASED 1.12.15 Prasco and Takeda Enter into Agreement to Market Authorized Generic of Colcrys® (colchicine, USP) in the United States Companies Committed to Providing Access to Colchicine Tablets Cincinnati, OH, Deerfield, Ill., January 12, 2015/PRNewswire/ — Prasco Laboratories (“Prasco”)...

 

2014

Prasco® Markets Authorized Generic of Hectorol® (doxercalciferol) 0.5, 1.0 & 2.5 mcg capsules

AS RELEASED 03.11.2014 at 10:30 am EST Prasco® Markets Authorized Generic of Hectorol® (doxercalciferol) 0.5, 1.0 & 2.5 mcg capsules Prasco has Begun Distribution of Doxercalciferol Capsules CINCINNATI, OH March 11, 2014 — Prasco Laboratories announced today it has begun shipping...

 

Eli Lilly and Company Expands Authorized Generic Agreements with Prasco®

AS RELEASED 4.1.14 at 9:10 am EDT Eli Lilly and Company Expands Authorized Generic Agreements with Prasco® Prasco to market the Authorized Generic of EVISTA® in the United States CINCINNATI, OH April 1, 2014 – Prasco Laboratories, announced today it has...

 

Prasco® Announces Authorized Generic Agreement with Recordati

AS RELEASED 5.22.14 at 9:58 AM ET Prasco® Announces Authorized Generic Agreement with Recordati Prasco To Market Authorized Generic of NeoProfen® (ibuprofen lysine) Injection CINCINNATI, OH MAY 22, 2014/PRNewswire/ — Prasco Laboratories announced today it has entered into a distribution...

 

2013

Prasco Launches Authorized Generic of Lysteda® (tranexamic acid) Tablets

1.07.13 For Immediate Release Prasco Launches Authorized Generic of Lysteda® (tranexamic acid) Tablets - Ferring Pharmaceuticals Joins Prasco’s Growing Family of Brand Partners CINCINNATI, OH; 1/07/13 — Prasco Laboratories announced today it began shipping the Authorized Generic of Ferring’s LYSTEDA® (tranexamic...

 

Prasco announces agreement with WellSpring for the Authorized Generic of DIBENZYLINE®

AS RELEASED ON PRNEWSWIRE 05.01.2013 at 9:53 am EST Prasco announces agreement with WellSpring for the Authorized Generic of DIBENZYLINE® Prasco intends to launch DIBENZYLINE® upon first generic entrant CINCINNATI, OH; /May 1, 2013/— Prasco Laboratories announced today it has signed an exclusive distribution and...

 

Prasco announces agreement with Shire for the Authorized Generic of FOSRENOL® (lanthanum carbonate)

AS RELEASED ON PRNEWSWIRE 10.17.2013 at 9:15 am EST Prasco announces agreement with Shire for the Authorized Generic of FOSRENOL® (lanthanum carbonate) CINCINNATI, October 17, 2013 — Prasco Laboratories announced today it has signed an exclusive distribution and supply agreement...

 

2012

Prasco Launches Authorized Generic Nisoldipine Extended Release Tablets

Prasco Expands Relationship with Shionogi Inc.

 

Prasco Expands Authorized Generic Product Line with Vancocin® HCl Capsules

AS RELEASED ON PRNEWSWIRE 04.11.2012 at 11:00 am EST

 

Prasco® Launches Authorized Generic of Dovonex® Cream 0.005%

As released 8.20.2012 Prasco® Launches Authorized Generic of Dovonex® Cream 0.005% LEO Pharma Joins Prasco Family of Brand Partners CINCINNATI, OH; /August 8, 2012/— Prasco Laboratories will immediately begin distributing the Authorized Generic of Dovonex® (Calcipotriene) Cream, 0.005% in 60...

 

Prasco and Sunovion Pharmaceuticals Inc. enter into Authorized Generic Agreement for XOPENEX® (levalbuterol HCl) Inhalation Solution

8.20.12 For Immediate Release Prasco and Sunovion Pharmaceuticals Inc. enter into Authorized Generic Agreement for XOPENEX® (levalbuterol HCl) Inhalation Solution CINCINNATI, OH; 8/20/12 — Prasco Laboratories (Prasco) today announced that Prasco and Sunovion Pharmaceuticals Inc. (Sunovion) will immediately begin distributing...

 


View News Archive >

Where to go next?

 
 

CUSTOMER SERVICE
1.866.525.0688
Monday - Friday
8:30 AM - 5:00 PM EST


Need product information?

SEARCH PRODUCTS